Dr. Naim Zreik Farhat, MD

Dr. Farhat practices at UH Elyria Medical Center in Elyria, Ohio.

Dr. Farhat's NPI, 1881673234, was assigned on January 13, 2006. Dr. Farhat holds Ohio license 35051696.

Dr. Farhat's primary practice is UH Elyria Medical Center, at 630 E River St, Elyria, OH 44035 in Lorain County. The practice phone is (440) 329-7500.

Dr. Farhat's primary practice is UH Elyria Medical Center in Elyria, Ohio. Dr. Farhat is also affiliated with University Hospitals Elyria Medical Center. The medical group on file is University Eyecare. Dmand AI also links Dr. Farhat to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Farhat practices, 3 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Farhat's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Farhat is licensed in Ohio.

CMS data shows 1,465 Medicare services from Dr. Farhat across 15 procedure codes in 2024, for 788 Medicare patients. Medicare paid $116,934 for them.

CMS counts 788 Medicare patients who saw Dr. Farhat in 2024. The largest group is 75 to 84, with 324 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Farhat's median patient age at 74, with 41% women.

In 2024, Dr. Farhat wrote 8,711 Medicare Part D claims for 1,313 patients. 92% of them were for generic drugs. CMS names the drug for 8,459 of them, across 52 drugs with 11 or more claims each, at $783,098 in total drug cost. In 2023, CMS named 7,082 claims across 49 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Farhat for performance year 2024, reported through an alternative payment model (APM). Dr. Farhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 35 procedures of coronary angioplasty and stenting by Dr. Farhat, more than 72% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 14 papers to Dr. Farhat, published from 2010 to 2015. 2011 was the busiest year, with 3. The most frequent topics are Acute Coronary Syndrome, Coronary Artery Disease and Ultrasonography, Interventional. Dr. Farhat has published most often in JACC Cardiovasc Imaging. Dr. Farhat's most frequent co-authors are Robert Joseph Applegate, MD, Steven Patrick Marso, MD and Ronald P. Caputo, MD.

Dmand AI links Dr. Farhat to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 170 general payments to Dr. Farhat from 35 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 62% of the total. Medtronic Vascular, Inc. paid the most, $8,353. It also lists 2 research payments totaling $4,000 in 2020.